Merck & Co., Inc. (MRK) Earnings Date, Estimates & Call Transcripts $99.18 -0.68 (-0.68%) (As of 11/22/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Merck & Co., Inc. Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 6EstimatedActual EPS (Oct. 31) $1.57 Beat By $0.07 Consensus EPS (Oct. 31) $1.50 Merck & Co., Inc. announced Q3 2024 earnings on October 31, 2024, reporting an EPS of $1.57, which topped the consensus estimate of $1.50 by $0.07. Quarterly revenue rose 4.4% year-over-year to $16.66 billion, above analysts' expectations of $16.47 billion. With a trailing EPS of $4.77 and a P/E Ratio of 20.79, Merck & Co., Inc.'s earnings are expected to grow 21.99% next year, from $7.73 to $9.43 per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckMRK Upcoming EarningsMerck & Co., Inc.'s next earnings date is estimated for Thursday, February 6, 2025, based off prior year's reporting schedules. Get Merck & Co., Inc. Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merck & Co., Inc. and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMRK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MRK Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Genesis Gold GroupBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now Merck & Co., Inc. Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$1.80$2.07$1.96 Q2 20243$1.88$2.10$2.00 Q3 20243$1.46$2.27$1.93 Q4 20243$1.82$2.25$2.06 FY 202412$6.96$8.69$7.96 Q1 20252$2.22$2.37$2.30 Q2 20252$2.38$2.42$2.40 Q3 20252$2.43$2.49$2.46 Q4 20252$2.09$2.44$2.27 FY 20258$9.12$9.72$9.42 Q1 20261$2.34$2.34$2.34 Q2 20261$2.62$2.62$2.62 Q3 20261$2.65$2.65$2.65 Merck & Co., Inc. Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/6/2025(Estimated)------- 10/31/2024Q3 2024$1.50$1.57+$0.07$1.90$16.47B$16.66B 7/30/2024Q2 2024$2.16$2.28+$0.12$2.42$15.87B$16.10B 4/25/2024Q1 2024$1.94$2.07+$0.13$2.27$15.21B$15.78B 2/1/2024Q4 2023-$0.09$0.03+$0.12$0.54$14.49B$14.63B 10/26/2023Q3 2023$1.94$2.13+$0.19$2.40$15.30B$16.00B 8/1/2023Q2 2023-$2.18-$2.06+$0.12-$1.77$14.44B$15.04B Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link.4/27/2023Q1 2023$1.34$1.40+$0.06$1.69$13.81B$14.49B 2/2/2023Q4 2022$1.56$1.62+$0.06$2.06$13.66B$13.83B Merck & Co., Inc. Earnings - Frequently Asked Questions When is Merck & Co., Inc.'s earnings date? Merck & Co., Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based off last year's report dates. Learn more on MRK's earnings history. What guidance has Merck & Co., Inc. issued on next quarter's earnings? Merck & Co., Inc. updated its FY24 earnings guidance on Thursday, October, 31st. The company provided earnings per share (EPS) guidance of $7.72-7.77 for the period, compared to the consensus earnings per share estimate of $7.75. The company issued revenue guidance of $63.6-64.1 billion, compared to the consensus revenue estimate of $64.14 billion. Did Merck & Co., Inc. beat their earnings estimates last quarter? In the previous quarter, Merck & Co., Inc. (NYSE:MRK) reported $1.57 earnings per share (EPS) to beat the analysts' consensus estimate of $1.50 by $0.07. Learn more on analysts' earnings estimate vs. MRK's actual earnings. How can I listen to Merck & Co., Inc.'s earnings conference call? The conference call for Merck & Co., Inc.'s latest earnings report can be listened to online. Listen to Conference Call How can I read Merck & Co., Inc.'s conference call transcript? The conference call transcript for Merck & Co., Inc.'s latest earnings report can be read online. Read Transcript How much revenue does Merck & Co., Inc. generate each year? Merck & Co., Inc. (NYSE:MRK) has a recorded annual revenue of $60.12 billion. How much profit does Merck & Co., Inc. generate each year? Merck & Co., Inc. (NYSE:MRK) has a recorded net income of $365 million. MRK has generated $4.77 earnings per share over the last four quarters. What is Merck & Co., Inc.'s price-to-earnings ratio? Merck & Co., Inc. (NYSE:MRK) has a trailing price-to-earnings ratio of 20.79 and a forward price-to-earnings ratio of 12.83. The price/earnings-to-growth ratio is 1.43. What is Merck & Co., Inc.'s EPS forecast for next year? Merck & Co., Inc.'s earnings are expected to grow from $7.73 per share to $9.43 per share in the next year, which is a 21.99% increase. ` More Earnings Resources from MarketBeat Related Companies LLY Earnings Results JNJ Earnings Results ABBV Earnings Results PFE Earnings Results BMY Earnings Results ZTS Earnings Results RPRX Earnings Results JAZZ Earnings Results CORT Earnings Results PRGO Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Buffett Dumps $982 Million in BofA Stock—What Does He Know? (Ad)Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now This page (NYSE:MRK) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredReality Check: Are You Prepared for What's Next?Global shifts, like the alliance of BRICS nations pushing for economic independence from the U.S. dollar, and ...Allegiance Gold | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck & Co., Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck & Co., Inc. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
